Header Logo

Connection

Alan Landay to DNA, Viral

Back to Details
This is a "connection" page, showing publications Alan Landay has written about DNA, Viral.
Alan Landay
Connection Strength
0.866
DNA, Viral
  1. Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS. 2020 05 01; 34(6):849-857.
    View in: PubMed
    Score: 0.173
  2. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals. AIDS. 2017 09 24; 31(15):2059-2067.
    View in: PubMed
    Score: 0.145
  3. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 2003 Mar 07; 17(4):455-80.
    View in: PubMed
    Score: 0.053
  4. Trophoblasts are productively infected by CD4-independent isolate of HIV type 1. AIDS Res Hum Retroviruses. 2002 Jan 01; 18(1):13-7.
    View in: PubMed
    Score: 0.049
  5. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021 06 29; 12(1):3922.
    View in: PubMed
    Score: 0.047
  6. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. mBio. 2021 02 23; 12(1).
    View in: PubMed
    Score: 0.046
  7. Induction of HIF-1a by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation. mBio. 2018 09 11; 9(5).
    View in: PubMed
    Score: 0.039
  8. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 08 16; 67(5):770-777.
    View in: PubMed
    Score: 0.038
  9. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol. 1998 Mar; 18(2):124-31.
    View in: PubMed
    Score: 0.037
  10. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 10 17; 216(7):813-818.
    View in: PubMed
    Score: 0.036
  11. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunol. 2018 03; 11(2):449-461.
    View in: PubMed
    Score: 0.036
  12. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J Acquir Immune Defic Syndr (1988). 1993 Feb; 6(2):171-5.
    View in: PubMed
    Score: 0.026
  13. Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis. 1990 Dec; 162(6):1239-44.
    View in: PubMed
    Score: 0.023
  14. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol. 2006 Oct; 80(20):10162-72.
    View in: PubMed
    Score: 0.017
  15. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis. 2006 Jul 01; 194(1):29-37.
    View in: PubMed
    Score: 0.016
  16. HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis. 2004 Aug 01; 190(3):619-23.
    View in: PubMed
    Score: 0.014
  17. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
    View in: PubMed
    Score: 0.013
  18. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest. 2001 Feb; 107(3):287-94.
    View in: PubMed
    Score: 0.011
  19. Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000 Oct 01; 25(2):150-6.
    View in: PubMed
    Score: 0.011
  20. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team. Blood. 2000 Jan 01; 95(1):48-55.
    View in: PubMed
    Score: 0.011
  21. Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis. 2000 Jan; 181(1):148-57.
    View in: PubMed
    Score: 0.011
  22. Absence of evidence for human spumaretrovirus sequences in patients with Graves' disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 01; 9(1):99-101.
    View in: PubMed
    Score: 0.008
  23. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 1994 Jan 05; 271(1):42-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.